<Disease><Name>ALPORT SYNDROME</Name><Synonym>ALPORT SYNDROME; NEPHROPATHY AND DEAFNESS, X-LINKED</Synonym><OMIM><Number>301050</Number><URL>http://omim.org/entry/301050</URL></OMIM><Orphanet><Number>63</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=63</URL></Orphanet><Protein><Number>Collagen alpha-5(IV) chain</Number><URL>http://www.uniprot.org/uniprot/P29400</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>Xq22.3</Gene><ICD>Q87.8</ICD><Summary>rare ;X-linked dominant; mutation in the collagen, type IV, alpha-5 gene</Summary><Symptoms><symtomp><id>1736</id><symptom>cataract</symptom><category>EYES</category></symtomp><symtomp><id>2564</id><symptom>DNA / deoxyribonucleic acid</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2161</id><symptom>eye defect beginning in infancy or childhood</symptom><category>EYES | GENERAL TOPICS</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2274</id><symptom>hematuria</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2114</id><symptom>ichthyosis</symptom><category>SKIN</category></symtomp><symtomp><id>2325</id><symptom>myopia</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2004</id><symptom>nephritis</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3985</id><symptom>nephropathy</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3168</id><symptom>nephrotic syndrome / neprhrotic syndrome</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3629</id><symptom>proteinuria</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2461</id><symptom>renal failure, acute/chronic</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>3199</id><symptom>thrombopenia, thrombocytopenia</symptom><category>LABORATORY FINDINGS</category></symtomp></Symptoms><Metabolites><metabolite><id>1111</id><name>Erythrocytes</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>12.00</max><unit>/&#181;l</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1096</id><name>Protein</name><specimen>urine</specimen><value>increased</value><min>50.00</min><max>80.00</max><unit>mg/24 hr</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1158</id><name>Thrombocytes, Platelets</name><specimen>blood</specimen><value>normal/dec</value><min>100.00</min><max>350.00</max><unit>x1000/&#181;l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1157</id><name>Thrombocytes, Platelets</name><specimen>blood</specimen><value>normal/dec</value><min>150.00</min><max>400.00</max><unit>x1000/&#181;l</unit><age>infant</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3610</id><title>Stem Cells Dev</title><author>Moschidou D,</author><journal /><year>2016</year><book /><volume>25</volume><number>5</number><pages>395-404</pages><co_aut>Human Chorionic Stem Cells: Podocyte Differentiation and Potential for the Treatment of Alport Syndrome.</co_aut></literature><literature><id>3611</id><title>Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome</title><author>Zhang Y,</author><journal>Pediatr Nephrol</journal><year>2016</year><book /><volume>31</volume><number>1</number><pages>67-72</pages><co_aut>et al.</co_aut></literature><literature><id>3612</id><title>Alport syndrome and pregnancy: Good obstetric and nephrological outcomes in a pregnant woman with homozygous autosomal recessiv</title><author>Nishizawa Y,</author><journal>J Obstet Gynaecol Res</journal><year>2016</year><book /><volume>42</volume><number>3</number><pages>331-335</pages><co_aut>et al.</co_aut></literature><literature><id>3613</id><title>Searching for a treatment for Alport syndrome using mouse models</title><author>Katayama K,</author><journal>World J Nephrol</journal><year>2014</year><book /><volume>3</volume><number>4</number><pages>230-236</pages><co_aut>et al.</co_aut></literature><literature><id>3614</id><title>DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome</title><author>International Alport Mutation Consortium</author><journal>Pediatr Nephrol</journal><year>2014</year><book /><volume>29</volume><number>6</number><pages>971-977</pages><co_aut /></literature><literature><id>3615</id><title>X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.</title><author>Pierides A,</author><journal>Hippokratia</journal><year>2013</year><book /><volume>17</volume><number>3</number><pages>207-213</pages><co_aut>et al.</co_aut></literature><literature><id>3616</id><title>An update on the pathomechanisms and future therapies of Alport syndrome</title><author>Noone D,</author><journal>Pediatr Nephrol</journal><year>2013</year><book /><volume>28</volume><number>7</number><pages>1025-1036</pages><co_aut>Licht C</co_aut></literature><literature><id>2899</id><title>Treatment of Alport syndrome: beyond animal models</title><author>Gross O</author><journal>Kidney Int</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Kashtan CE</co_aut></literature><literature><id>2901</id><title>Retinal Findings in Patients with Alport Syndrome: Expanding the Clinical Spectrum</title><author>Fawzi AA</author><journal>Br J Ophthalmol</journal><year>2009</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2900</id><title>Stem cell therapy for Alport syndrome: the hope beyond the hype</title><author>Gross O</author><journal>Nephrol Dial Transplant</journal><year>2008</year><book /><volume>24</volume><number>3</number><pages>731-734</pages><co_aut>et al.</co_aut></literature><literature><id>1624</id><title>Mouse model of x-linked alport syndrome</title><author>Rheault MN</author><journal>J Am Soc Nephrol</journal><year>2004</year><book /><volume>15</volume><number>6</number><pages>1466-1474</pages><co_aut>et al.</co_aut></literature><literature><id>1625</id><title>A large tandem duplication within the COL4A5 gene is responsible for the high prevalence of Alport syndrome in French Polynesia</title><author>Arrondel C</author><journal>Kidney Int</journal><year>2004</year><book /><volume>65</volume><number>5</number><pages>2030-2040</pages><co_aut>et al.</co_aut></literature><literature><id>1626</id><title>Expression of the partial protein encoded by mutated COL4A5 gene and analysis of the structure by circular dichroism</title><author>Wang YF</author><journal>Beijing Da Xue Xue Bao</journal><year>2004</year><book /><volume>36</volume><number>2</number><pages>185-189</pages><co_aut>et al.</co_aut></literature><literature><id>1627</id><title>Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene</title><author>Pescucci C</author><journal>Kidney Int</journal><year>2004</year><book /><volume>65</volume><number>5</number><pages>1598-1603</pages><co_aut>et al.</co_aut></literature><literature><id>1628</id><title>Familial hematuria due to type IV collagen mutations: alport syndrome and thin basement membrane nephropathy</title><author>Kashtan CE</author><journal>Curr Opin Pediatr</journal><year>2004</year><book /><volume>16</volume><number>2</number><pages>177-181</pages><co_aut /></literature><literature><id>1235</id><title>Autosomal recessive Alports syndrome and benign familial hematuria are collagen type IV diseases</title><author>Vega BT</author><journal>Am J Kidney Dis</journal><year>2003</year><book /><volume>42</volume><number>5</number><pages>952-959</pages><co_aut>et al.</co_aut></literature><literature><id>1236</id><title>X-linked alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a E</title><author>Jais JP</author><journal>J Am Soc Nephrol</journal><year>2003</year><book /><volume>14</volume><number>10</number><pages>2603-2610</pages><co_aut>et al.</co_aut></literature><literature><id>1234</id><title>Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes</title><author>Kashtan CE</author><journal>Medicine (Baltimore)</journal><year>1999</year><book /><volume>78</volume><number>5</number><pages>338-360</pages><co_aut /></literature><literature><id>429</id><title>Alport syndrome: clinical experience with 21 paediatric patients</title><author>Barten S</author><journal>Eur J Pediatr</journal><year>1996</year><book /><volume>155</volume><number>0</number><pages>49-52</pages><co_aut>Proesmans W</co_aut></literature><literature><id>184</id><title>Disorders of collagen biosynthesis and structure</title><author>Byers PH</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>3</volume><number>134</number><pages>4029-4077</pages><co_aut /></literature><literature><id>343</id><title>Alport syndrome: clinical update</title><author>Wester DC</author><journal>J Am Acad Audiol</journal><year>1995</year><book /><volume>6</volume><number>1</number><pages>73-79</pages><co_aut>Atkin CL, Gregory MC</co_aut></literature></Literatures></Disease>